Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 12/20 | 0.68 |
| ▸ | CNR2 | P34972 | 9/20 | 0.68 |
| ▸ | DAGLA | Q9Y4D2 | 3/20 | 0.68 |
| ▸ | LDHA | P00338 | 2/20 | 0.68 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.68 |
| ▸ | PPARG | P37231 | 1/20 | 0.68 |
| ▸ | NAAA | Q02083 | 1/20 | 0.60 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.42 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ABHD12 | Q8N2K0 | 2/20 | 0.40 |
| ▸ | ABHD6 | Q9BV23 | 2/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.40 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.40 |
| ▸ | GPR183 | P32249 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25878237 | 1.00 | CNR1 (0.68) | CNR1CNR2DAGLALDHATRPM8 | |
| SCHEMBL25878233 | 1.00 | CNR1 (0.68) | CNR1CNR2DAGLALDHATRPM8 | |
| SCHEMBL22424730 | 0.90 | CNR2 (0.62) | CNR1CNR2DAGLALDHATRPM8 | |
| SCHEMBL22424732 | 0.90 | CNR2 (0.62) | CNR1CNR2DAGLALDHATRPM8 | |
| SCHEMBL24476544 | 0.88 | CNR1 (0.52) | CNR1CNR2DAGLALDHATRPM8 | |
| SCHEMBL23635198 | 0.86 | CNR1 (0.50) | CNR1CNR2DAGLALDHATRPM8 | |
| Delta9-Tetrahydrocannabinolic Acid A SCHEMBL23076463 | 0.81 | CNR2 (1.00) | CNR1CNR2DAGLALDHATRPM8 | |
| SCHEMBL21424946 | 0.81 | CNR1 (0.66) | CNR1CNR2DAGLALDHATRPM8 | |
| SCHEMBL23258337 | 0.81 | CNR1 (0.66) | CNR1CNR2DAGLALDHATRPM8 | |
| Delta9-Tetrahydrocannabinolic Acid A SCHEMBL6856735 | 0.81 | CNR2 (1.00) | CNR1CNR2DAGLALDHATRPM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11707444-B2 | Antiviral composition for SARS-CoV-2 containing cannabinoids as active ingredient | RESEARCH COOPERATION FOUNDATION OF YEUNGNAM UNIVERSITY (KR) | 2023-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11707444-B2 | Antiviral composition for SARS-CoV-2 containing cannabinoids as active ingredient | TMPRSS2, ACE2, CNR2 | CNR1 4/4885CNR2 3/4885DAGLA 250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.